๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The objectives of this study are to examine the therapeutic effects of two ...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01698684
Treatments Being Tested
This study is being conducted to compare the safety and efficacy of 3 doses...
Status
Completed
Location
Research Site
Start Date
2008-11
Trial ID
NCT00790751
The purpose of this study is to see if avanafil causes any changes in blood...
Status
Completed
Location
MDS Pharma Services Inc.,
Start Date
2010-02
Trial ID
NCT01100021
Treatments Being Tested
This study will compare the pharmacokinetics of omeprazole, rosiglitazone a...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01415128
Treatments Being Tested
This study is designed to look into the effect of avanafil on blood levels ...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01095588
Treatments Being Tested
The objectives of this study are to evaluate the safety and efficacy of two...
Status
Completed
Location
Research Site
Start Date
2009-04
Trial ID
NCT00895011
This study is being conducted to examine the effect of three CYP3A4 inhibit...
Status
Completed
Location
Research Site
Start Date
2008-10
Trial ID
NCT00770042
Treatments Being Tested
This open-label study is being conducted to evaluate the long-term safety, ...
Status
Completed
Location
Research Site
Start Date
2009-03
Trial ID
NCT00853606
Treatments Being Tested
This study is being conducted to compare the safety and efficacy of 2 doses...
Status
Completed
Location
Research Site
Start Date
2008-12
Trial ID
NCT00809471
The objective of this study is to assess the single dose pharmacokinetics o...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01054430
Treatments Being Tested